Cambridge Epigenetix Ltd.

Cambridge Epigenetix Ltd.

Cambridge Epigenetix Ltd.

Overview
Date Founded

2012

Headquarters

The Trinity Building,Chesterford Research Park,Cambridge, Cambridgeshire CB10 1XL

Type of Company

Private

Employees (Worldwide)

51 - 100

Industries

Other Business & Consulting Services
Hospitals & Patient Services
IT Consulting & Services
Holding Companies
Medical Support Services
Biotechnology

Company Description

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Contact Data
Trying to get in touch with decision makers at Cambridge Epigenetix Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Head-Strategy

Director

Senior BioInformatics Scientist

Board of Directors

Chief Strategy Officer at Microsoft Corporation

Advisor at Avelas Biosciences, Inc.

General Partner at Google Ventures

Partner at Sequoia Capital

Former Investment Analyst at AKO Capital LLP

Assistant Professor at Hofstra University

Paths to Cambridge Epigenetix Ltd.
Potential Connections via
Relationship Science
You
Cambridge Epigenetix Ltd.
Recent Transactions
Details Hidden

Cambridge Epigenetix Ltd. raised money in a private placement transaction

Advisors & Consultants
Scientific Advisor

Managing Director at Ashleworth House Consulting Ltd.

Scientific Advisor
Investors
Details Hidden

DNA Capital is an active manager which provides equity financing for middle-market and early-stage capital requirements. The firm targets the healthcare sector and invests globally.

Details Hidden

AIC focuses on science and technology companies located in the UK. The firm provides long-term capital and support to exceptional founders and teams, empowering them to achieve the unimaginable.

Details Hidden

Syncona Partners LLP provides financial resources to individuals and companies. It operates as an investment company, taking an active role in identifying, supporting and developing technologies with the potential to significantly impact the healthcare market of the future. The firm focus on healthcare companies with defendable technology or transformational business models and can invest at any stage. The company was founded in 2012 and is headquartered in London, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cambridge Epigenetix Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cambridge Epigenetix Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cambridge Epigenetix Ltd..